Back to mobile site

More on NRXP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

NRx Pharmaceuticals (NQ:NRXP)
Delayed: 3.76 --0 (-0%)
Prev. Close $3.76  
Open$3.76 
52 Wk High$ 
52 Wk Low$ 
Day High$3.76 
Day Low$3.76 
P/E N/A  
EPS$ 
Volume13,628 

Friends, Peers and Foes (?): DVLT, SNYR, RDZN, MDCX, CISO (more...)

Jun 5, 2026 08:52 AM Osmind study finds IV ketamine more effective than nasal esketamine for depression
Jun 5, 2026 08:50 AM NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
Jun 4, 2026 05:20 PM Form 8-K NRX Pharmaceuticals, For: Jun 03
Jun 4, 2026 05:12 PM NRX Pharmaceuticals closes $22.3 million stock offering
Jun 4, 2026 05:12 PM NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
Jun 3, 2026 04:11 PM Form 424B5 NRX Pharmaceuticals,
Jun 3, 2026 08:18 AM NRx Pharmaceuticals prices public offering at $3.50 per share
Jun 3, 2026 08:18 AM NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
Jun 2, 2026 05:30 PM Form 8-K NRX Pharmaceuticals, For: Jun 02
Jun 2, 2026 05:28 PM Form 424B5 NRX Pharmaceuticals,
View All Articles

Entities mentioned with NRXP

View All Entities